Ingredion has announced a recommended all-cash offer to acquire the British ingredients group Tate & Lyle in a deal with an enterprise value of approximately 3.7 billion GBP (4.7 billion USD). Headquartered in Westchester, Illinois, Ingredion is a leading global ingredient solutions provider that processes grains, fruits, vegetables, and other plant-based materials into value-added components—including sweeteners, starches, and nutrition ingredients—for the food, beverage, brewing, and pharmaceutical industries.
Under the terms of the agreement, shareholders of Tate & Lyle will receive 595 pence per share in cash, plus additional dividends totaling up to 20 pence per share. This package represents a total offer value of 615 pence per share, a 64% premium over the company’s closing share price on May 13, 2026. The acquisition has received the unanimous support of the Tate & Lyle board of directors and has secured irrevocable voting undertakings from key shareholders, including Huber Equity Corporation.
The merger is designed to unify complementary geographic supply networks across North America, Europe, the Middle East, Africa, and the Asia Pacific region. Jim Zallie, the chairman, president, and CEO of Ingredion, highlighted the move as a milestone in providing customers with affordable, high-quality, and healthier product options. The combined entity is expected to generate nearly 10 billion USD in annual revenue and approximately 1.8 billion USD in adjusted EBITDA. To support the transaction, Ingredion has arranged a 4.2 billion USD bridge financing facility led by JPMorgan Chase Bank.
Market analysts view the deal as a strategic pivot toward high-margin specialty ingredients, particularly as traditional food volumes face pressure from shifting consumer habits and the rise of GLP-1 weight-loss drugs. The transaction is expected to yield 130 million USD in annual run-rate cost synergies by the end of 2030, with integration costs estimated at 175 million USD. The deal is slated to close in the second half of 2027, subject to regulatory clearances and the sanction of the High Court of Justice in England and Wales. This acquisition follows other recent portfolio expansions by Ingredion, including the purchase of Benicaros, a patented prebiotic fiber, announced earlier in June.
